Psychiatrist-St. Louis (1099)-Greenbrook

Neuronetics; St. Louis (MO); On-site; USD 230,000 - 320,000; Full time

Benefits offered by this job

No nights/weekends

Competitive compensation

TMS training provided

Job summary

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments in St. Louis, MO.

In this role you will support the Spravato program and collaborate with a multidisciplinary team to grow access to FDA-cleared therapies for patients with treatment-resistant depression.

Qualifications

• MD or DO.
• Board Certified or Board Eligible.
• Active Missouri medical license (or ability to obtain).
• DEA registration (or ability to obtain).

Responsibilities

• Provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments.
• Support the growth of the Spravato (esketamine) program in St. Louis, MO.
• Collaborate with a multidisciplinary team to advance patient access to FDA-cleared therapies.

Education

MD or DO

Job description

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in St. Louis, MO.

Why Join Us?

• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders

Qualifications

• MD or DO
• Board Certified or Board Eligible
• Active Missouri medical license (or ability to obtain)
• DEA registration (or ability to obtain)

About Greenbrook

As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients . Our mission is to transform mental health care and improve lives through innovative solutions.

Depression affects more than 16 million Americans . At Greenbrook, we’re changing the way it’s treated—and you can be part of that change.

Neuronetics, Inc. is a leading mental health company dedicated to transforming lives through innovative treatments. Now joined with Greenbrook Mental Wellness Centers, we offer FDA-cleared NeuroStar® TMS and Spravato® therapies for major depressive disorder and treatment-resistant depression across 95+ clinics nationwide. Together, we’re expanding access to life-changing care—combining cutting‑edge technology with clinical expertise to make a real impact in the mental health space.